Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reifsnyder, P. C.
Right arrow Articles by Leiter, E. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reifsnyder, P. C.
Right arrow Articles by Leiter, E. H.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Diabetes 51:825-832, 2002
© 2002 by the American Diabetes Association, Inc.

Deconstructing and Reconstructing Obesity-Induced Diabetes (Diabesity) in Mice

Peter C. Reifsnyder, and Edward H. Leiter

From the Jackson Laboratory, Bar Harbor, Maine

Obesity-driven type 2 diabetes (diabesity) involves complex genetic and environmental interactions to trigger disease. Here, we combine variable numbers of known quantitative trait loci (QTL) for obesity and diabetes contributed by New Zealand Obese (NZO/HlLt) and Nonobese Nondiabetic (NON/Lt) strains in the form of 10 interval-directed recombinant congenic strains (RCS), with NON/Lt as the background strain, to dissect the genetic interactions involved. All 10 RCS gain significantly more weight than the NON parental strain, but none are as obese as the parental, diabetes-prone NZO. Diabetes development in these RCS at F12 ranges between 0 and 100%, depending on genetic constitution. RCS-2, -1, and -10 represent a step-wise increase in numbers of specific diabetogenic QTL, resulting in a step-wise increase in diabetes incidence. RCS-10 recreates the 100% incidence seen in (NZOxNON)F1 males, but with less weight gain. Similarly, RCS-6, -7, -8, and -9 represent diabetes-prone strains with different combinations of diabetogenic QTL. RCS-3, -4, and -5 represent obese strains that do not transit to diabetes. Because these obesity and diabetes syndromes reflect different collections of QTL, rather than null mutations in the leptin or leptin receptor genes, they are extremely relevant as models for the polygenic obesity/diabesity syndromes in humans.



Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
Y.-R. Cho, H.-J. Kim, S.-Y. Park, H. J. Ko, E.-G. Hong, T. Higashimori, Z. Zhang, D. Y. Jung, M. S. Ola, K. F. LaNoue, et al.
Hyperglycemia, maturity-onset obesity, and insulin resistance in NONcNZO10/LtJ males, a new mouse model of type 2 diabetes
Am J Physiol Endocrinol Metab, July 1, 2007; 293(1): E327 - E336.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
S. M. Clee and A. D. Attie
The Genetic Landscape of Type 2 Diabetes in Mice
Endocr. Rev., February 1, 2007; 28(1): 48 - 83.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
S. A. Shore
Obesity and asthma: lessons from animal models
J Appl Physiol, February 1, 2007; 102(2): 516 - 528.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
N. Luo, S. M. Liu, H. Liu, Q. Li, Q. Xu, X. Sun, B. Davis, J. Li, and S. Chua Jr.
Allelic Variation on Chromosome 5 Controls {beta}-Cell Mass Expansion during Hyperglycemia in Leptin Receptor-Deficient Diabetes Mice
Endocrinology, May 1, 2006; 147(5): 2287 - 2295.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
E. H. Leiter, P. C. Reifsnyder, W. Zhang, H.-j. Pan, Q. Xiao, and J. Mistry
Differential Endocrine Responses to Rosiglitazone Therapy in New Mouse Models of Type 2 Diabetes
Endocrinology, February 1, 2006; 147(2): 919 - 926.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
K. Togawa, M. Moritani, H. Yaguchi, and M. Itakura
Multidimensional genome scans identify the combinations of genetic loci linked to diabetes-related phenotypes in mice
Hum. Mol. Genet., January 1, 2006; 15(1): 113 - 128.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
H.-J. Pan, P. Reifsnyder, D. E. Vance, Q. Xiao, and E. H. Leiter
Pharmacogenetic Analysis of Rosiglitazone-Induced Hepatosteatosis in New Mouse Models of Type 2 Diabetes
Diabetes, June 1, 2005; 54(6): 1854 - 1862.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
Y. Hu, D. Belke, J. Suarez, E. Swanson, R. Clark, M. Hoshijima, and W. H. Dillmann
Adenovirus-Mediated Overexpression of O-GlcNAcase Improves Contractile Function in the Diabetic Heart
Circ. Res., May 13, 2005; 96(9): 1006 - 1013.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
M. D. Breyer, E. Bottinger, F. C. Brosius III, T. M. Coffman, R. C. Harris, C. W. Heilig, K. Sharma, and for the AMDCC
Mouse Models of Diabetic Nephropathy
J. Am. Soc. Nephrol., January 1, 2005; 16(1): 27 - 45.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
K. Almind and C. R. Kahn
Genetic Determinants of Energy Expenditure and Insulin Resistance in Diet-Induced Obesity in Mice
Diabetes, December 1, 2004; 53(12): 3274 - 3285.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
J. Kaput, K. G. Klein, E. J. Reyes, W. A. Kibbe, C. A. Cooney, B. Jovanovic, W. J. Visek, and G. L. Wolff
Identification of genes contributing to the obese yellow Avy phenotype: caloric restriction, genotype, diet x genotype interactions
Physiol Genomics, August 11, 2004; 18(3): 316 - 324.
[Abstract] [Full Text] [PDF]


Home page
PhysiologyHome page
J. Mullerova and P. Hozak
Use of Recombinant Congenic Strains in Mapping Disease-Modifying Genes
Physiology, June 1, 2004; 19(3): 105 - 109.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
M. I. McCarthy
Progress in defining the molecular basis of type 2 diabetes mellitus through susceptibility-gene identification
Hum. Mol. Genet., April 1, 2004; 13(suppl_1): R33 - R41.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
E. H. Leiter and P. C. Reifsnyder
Differential Levels of Diabetogenic Stress in Two New Mouse Models of Obesity and Type 2 Diabetes
Diabetes, February 1, 2004; 53(90001): S4 - 11.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
D. C. Albarado, J. McClaine, J. M. Stephens, R. L. Mynatt, J. Ye, A. W. Bannon, W. G. Richards, and A. A. Butler
Impaired Coordination of Nutrient Intake and Substrate Oxidation in Melanocortin-4 Receptor Knockout Mice
Endocrinology, January 1, 2004; 145(1): 243 - 252.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. Rossmeisl, J. S. Rim, R. A. Koza, and L. P. Kozak
Variation in Type 2 Diabetes-Related Traits in Mouse Strains Susceptible to Diet-Induced Obesity
Diabetes, August 1, 2003; 52(8): 1958 - 1966.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. Kobayashi, T. Ohno, A. Tsuji, M. Nishimura, and F. Horio
Combinations of Nondiabetic Parental Genomes Elicit Impaired Glucose Tolerance in Mouse SMXA Recombinant Inbred Strains
Diabetes, January 1, 2003; 52(1): 180 - 186.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2002 by the American Diabetes Association.